Frailty of Elderly With Valvular Heart Disease and the Short Term Adverse Events
NCT ID: NCT05014750
Last Updated: 2022-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2021-09-01
2022-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on Optimal Treatment Strategy for Elderly Patients With High-risk Complex Aortic Valve Disease
NCT05044377
China Senile Valvular Heart Disease Cohort Study
NCT02865798
China Valve Registry Study-1
NCT02623907
Valvular Heart Disease Registry Study in Second Affiliated Hospital of ZheJiang University
NCT03011697
Valvular Heart Disease in Jiangxi Province
NCT05523193
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
None intervention
There is no intervention included in this study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to continue to participate in this study;
* Diagnosed as valvular heart disease
Exclusion Criteria
* with severe mental disorders;
* cannot accept frailty assessment due to treatment needs and other factors.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zhiyun Shen
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Frailty Study 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.